换一批
换一批miR-130a and miR-145 reprogram Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid cells and inhibit tumor metastasis through improved host immunity.
作者：
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);细胞系, 肿瘤(Cell Line, Tumor);药物评价, 临床前(Drug Evaluation, Preclinical);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);免疫, 先天(Immunity, Innate);注射, 静脉内(Injections, Intravenous);干扰素γ(Interferon-gamma);肺肿瘤(Lung Neoplasms);乳房肿瘤, 实验性(Mammary Neoplasms, Experimental);小鼠(Mice);小鼠, 转基因(Mice, Transgenic);微RNAs(MicroRNAs);髓系细胞(Myeloid Cells);寡核糖核苷酸类(Oligoribonucleotides);焦没食子酚(Pyrogallol);受体, IGF1型(Receptor, IGF Type 1);受体, 趋化因子(Receptors, Chemokine);信号传导(Signal Transduction);磺胺类(Sulfonamides);转化生长因子β(Transforming Growth Factor beta)
DOI
10.1038/s41467-018-05023-9
PMID
29973593
发布时间
2023-12-13
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
